Teva Pharmaceutical ( Teva Pharmaceutical )

Teva Pharmaceutical

Teva Pharmaceutical's picture

The foundation of our success, and at the heart of Teva, is our vision to be the most indispensable medicines company for the world, executing on our obligation to our patients, customers, shareholders and employees.

Established in 1901, today we rank among the 10 top pharmaceutical companies in the world. Headquartered in Israel, Teva is active in 60 countries, with over 46,400 dedicated employees worldwide.

Teva Pharmaceutical press release, blog etc

05/23/2018 - 04:21 Teva Confirms September PDUFA Date for Fremanezumab
05/18/2018 - 14:58 CORRECTING and REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association
05/15/2018 - 09:43 Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association
05/02/2018 - 07:20 Teva to Present AUSTEDO (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual Meeting
04/26/2018 - 18:40 Teva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE (glatiramer acetate injection) 40 mg/mL
04/19/2018 - 07:01 Teva and the Procter & Gamble Company Have Agreed to Terminate the PGT Healthcare Partnership
03/26/2018 - 12:01 Teva Announces the Launch of a Generic Version of Lialda in the United States
03/23/2018 - 13:42 Teva Announces the Launch of a Generic Version of ALOXI in the United States
03/12/2018 - 08:36 Teva to Present at the Cowen & Company 38th Annual Healthcare Conference
03/07/2018 - 14:27 Teva Announces Upsizing and Successful Pricing of $4.5 Billion of Senior Notes
02/28/2018 - 07:27 Teva Announces Launch of Offering of Senior Notes
02/20/2018 - 02:11 Teva Announces Exclusive Launch of Two Strengths of a Generic Version of Solodyn in the United States
02/12/2018 - 08:17 Teva Announces U.S. Launch of QVAR RediHaler (Beclomethasone Dipropionate HFA) Inhalation Aerosol
02/09/2018 - 11:43 Teva Announces Launch of a Generic Version of Syprine in the United States
02/02/2018 - 09:34 European Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization Application
02/01/2018 - 07:00 Teva Announces Completion of Global Womens Health Divestiture to CVC Capital Partners
01/22/2018 - 03:09 Teva Announces Top-Line Results from Phase III Studies of Subcutaneously Administered Reslizumab in Patients with Severe Eosinophilic Asthma
01/15/2018 - 01:31 Teva Announces U.S. FDA Approval of TRISENOX (arsenic trioxide) Injection for First Line Treatment of Acute Promyelocytic Leukemia